Veeva Vault CRM Selected by Eli Lilly and Company
PLEASANTON, Calif., Aug. 11, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Eli Lilly and Company (Lilly) has committed to Veeva Vault CRM globally.
PRNewsWire8/11/2026Neutral
VEEV
Veeva Systems Inc Class ANYSEHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$38.72B
P/E Ratio
43.26
EPS
$5.51
Beta
0.92
52W High
$310.50
52W Low
$148.05
50-Day MA
$190.05
200-Day MA
$200.83
Dividend Yield
—
Profit Margin
28.40%
Forward P/E
27.10
PEG Ratio
1.10
About Veeva Systems Inc Class A
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
Fundamentals
| Revenue (TTM) | $3.32B |
| Gross Profit (TTM) | $2.49B |
| EBITDA | $1.03B |
| Operating Margin | 30.90% |
| Return on Equity | 13.90% |
| Return on Assets | 7.30% |
| Revenue/Share (TTM) | $20.26 |
| Book Value | $44.83 |
| Price-to-Book | 5.42 |
| Price-to-Sales (TTM) | 11.66 |
| EV/Revenue | 9.76 |
| EV/EBITDA | 32.53 |
| Quarterly Earnings Growth (YoY) | 14.60% |
| Quarterly Revenue Growth (YoY) | 16.30% |
| Shares Outstanding | $162.44M |
| Float | $148.85M |
| % Insiders | 8.58% |
| % Institutions | 93.36% |
Historical Volatility
HV 10-Day
44.01%
HV 20-Day
47.56%
HV 30-Day
41.64%
HV 60-Day
47.65%
HV Rank
69.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($244.14 target)
9
Strong Buy13
Buy7
Hold1
SellLatest News
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Zacks Investment Research8/10/2026Neutral
Veeva to Release Fiscal 2027 Second Quarter Results on August 26, 2026
PLEASANTON, Calif., Aug. 5, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter ending July 31, 2026 after market close on August 26, 2026.
PRNewsWire8/5/2026Neutral
Veeva Systems: A 'Buy' Because The Narrative Has Outrun The Fundamentals
Veeva Systems has underperformed the S&P 500 despite strong fundamentals and improving profitability. VEEV's revenue grew 16% year-over-year, gross profit rose to the mid-70s, and cash generation nearly doubled to $1.665 billion TTM. The transition from Salesforce to Vault CRM is progressing, but AI initiative ROI doubts and migration risks weigh on sentiment.
Seeking Alpha7/31/2026Positive
Veeva Systems: Steady Execution, Attractive P/E Multiples
Veeva Systems stands out as a compelling buy amid a potential market rotation into lagging software stocks. VEEV benefits from a highly regulated customer base, strong growth and margin profile, and robust sales execution. After a near-20% YTD decline and recent post-earnings volatility, VEEV's valuation is now especially attractive.
Seeking Alpha7/24/2026Positive
Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Zacks Investment Research7/23/2026Neutral
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.
Zacks Investment Research7/23/2026Positive
Veeva Systems (VEEV) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research7/22/2026Positive
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
VEEV's strong Q1, growing Vault CRM migrations and AI expansion support growth, though life sciences CRM market saturation poses risks.
Zacks Investment Research7/15/2026Positive
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Veeva Systems (VEEV) settling at $193.09, representing a -1.89% change from its previous close.
Zacks Investment Research7/14/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on VEEV and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 8/18/2026